MindBio Therapeutics 

$0.86
0
-$0.03-3.21% Wednesday 13:56

Statistik

Tertinggi harian
0.6
Paras terendah hari ini
0.6
Tertinggi 52M
2.44
Paras terendah 52M
0.28
Volum
2,000
Vol. purata
4,952
Kap. pasaran
0
Nisbah P/E
-
Hasil dividen
-
Dividen
-

Orang juga ikut

Senarai ini berdasarkan senarai pantauan pengguna Stock Events yang mengikuti MBQIF. Ia bukan cadangan pelaburan.

Pesaing

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.

Perihal

MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for developing novel and clinically proven treatments for debilitating health conditions, such as depression, anxiety, PTSD, and chronic pain. MindBio Therapeutics Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Justin Adam Hanka
Negara
DE
ISIN
CA60256C2076

Penyenaraian

0 Comments

Kongsi pendapat anda

FAQ

Berapakah harga saham MindBio Therapeutics hari ini?
Harga semasa MBQIF ialah $0.86 USD — telah menurun sebanyak -3.21% dalam 24 jam yang lalu. Pantau prestasi harga saham MindBio Therapeutics dengan lebih dekat pada carta.
Apakah simbol saham MindBio Therapeutics?
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham MindBio Therapeutics didagangkan di bawah simbol MBQIF.
Bilakah MindBio Therapeutics menyiapkan split saham?
MindBio Therapeutics tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat MindBio Therapeutics?
Ibu pejabat MindBio Therapeutics terletak di Vancouver, DE.